LEAP THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Feb 2025)
What this means for you
Registered since 18 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86790294
- Registration number
- 5633221
- Mark type
- Stylized text
- Filed
- 16 Oct 2015
- Published for opposition
- 22 Mar 2016
- Registered
- 18 Dec 2018
- Attorney of record
- JOHN L. DUPRE'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer and cancer-related comorbidities in humans
Owner
- LEAP THERAPEUTICS, INC., CAMBRIDGE, MA, US
- CYPHERPUNK TECHNOLOGIES INC., CAMBRIDGE, MA, US
- LEAP THERAPEUTICS, INC., CAMBRIDGE, MA, US
- LEAP THERAPEUTICS, INC., CAMBRIDGE, MA, US
- LEAP THERAPEUTICS, INC., CAMBRIDGE, MA, US
- HealthCare Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 11 Feb 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Feb 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Oct 2024 — TEAS SECTION 8 & 15 RECEIVED
- 18 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Nov 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Oct 2018 — USE AMENDMENT FILED
- 10 Nov 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Oct 2018 — TEAS STATEMENT OF USE RECEIVED
- 04 May 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED